CPC
AZN icon

Cookson Peirce & Co’s AstraZeneca AZN Stock Holding History

Cookson Peirce & Co’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.72M Buy
9,055
+420
+5% +$79K 0.06% 158
2026
Q1 		$1.7M Buy
8,635
+825
+11% +$159K 0.07% 122
2025
Q4 		$1.44M Buy
7,810
+977
+14% +$171K 0.06% 143
2025
Q3 		$1.05M Buy
+6,833
New +$1.03M 0.04% 168
2025
Q2 		– Sell
-1,817
Closed -$267K – 277
2025
Q1 		$267K Buy
1,817
+125
+7% +$18.1K 0.01% 241
2024
Q4 		$222K Sell
1,692
-240,142
-99% -$33.6M 0.01% 254
2024
Q3 		$37.7M Buy
+241,834
New +$39M 1.77% 17
2023
Q3 		– Sell
-1,916
Closed -$274K – 206
2023
Q2 		$274K Sell
1,916
-60
-3% -$8.83K 0.02% 181
2023
Q1 		$274K Hold
1,976
– – 0.02% 181
2022
Q4 		$268K Sell
1,976
-253,780
-99% -$31.8M 0.02% 169
2022
Q3 		$28.1M Buy
255,756
+592
+0.2% +$75.1K 1.98% 14
2022
Q2 		$33.7M Buy
+255,164
New +$33.5M 2.32% 8
2021
Q4 		– Sell
-1,805
Closed -$217K – 207
2021
Q3 		$217K Buy
+1,805
New +$210K 0.01% 203
2020
Q4 		– Sell
-89,220
Closed -$9.78M – 157
2020
Q3 		$9.78M Buy
89,220
+27,572
+45% +$3.07M 0.73% 44
2020
Q2 		$6.52M Sell
61,648
-1,596
-3% -$165K 0.61% 47
2020
Q1 		$5.65M Sell
63,244
-108,810
-63% -$10.2M 0.65% 45
2019
Q4 		$17.2M Sell
172,054
-5,036
-3% -$474K 1.51% 26
2019
Q3 		$15.8M Sell
177,090
-4,975
-3% -$431K 1.38% 31
2019
Q2 		$15M Buy
182,065
+30
+0% +$2.35K 1.26% 33
2019
Q1 		$14.7M Sell
182,035
-840
-0.5% -$66.2K 1.24% 36
2018
Q4 		$13.9M Buy
+182,875
New +$14.3M 1.34% 32

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

Cookson Peirce & Co's AZN Position: Q2 2026 in Review

Cookson Peirce & Co increased its AstraZeneca (AZN) stake by 4.9% in Q2 2026, buying an estimated $79K and bringing the position to 9,055 shares worth $1.72M. The position accounts for 0.06% of the portfolio, ranked #158.

Cookson Peirce & Co first reported a position in AZN in Q4 2018 and has held it in 21 quarters since. The position peaked at $37.7M in Q3 2024. 443 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Cookson Peirce & Co held 9,055 shares of AstraZeneca worth $1.72M as of Q2 2026.
  • Cookson Peirce & Co bought 420 AstraZeneca shares in Q2 2026, an estimated $79K.
  • AstraZeneca made up 0.06% of Cookson Peirce & Co's portfolio in Q2 2026, its #158 holding.
  • Cookson Peirce & Co first reported a position in AstraZeneca in Q4 2018 and has held it in 21 quarters since.
  • Cookson Peirce & Co's AstraZeneca position peaked at $37.7M in Q3 2024.
  • 443 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Cookson Peirce & Co's 13F filing for Q2 2026, filed 23 Jul 2026.